CervoMed Statistics

Total Valuation

CervoMed has a market cap or net worth of $84.24 million. The enterprise value is $34.27 million.

Market Cap	84.24M
Enterprise Value	34.27M

Important Dates

The next estimated earnings date is Tuesday, May 13, 2025, after market close.

Earnings Date	May 13, 2025
Ex-Dividend Date	n/a

Share Statistics

CervoMed has 8.70 million shares outstanding. The number of shares has increased by 203.34% in one year.

Current Share Class	8.70M
Shares Outstanding	8.70M
Shares Change (YoY)	+203.34%
Shares Change (QoQ)	+0.05%
Owned by Insiders (%)	33.38%
Owned by Institutions (%)	17.24%
Float	5.80M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	7.04
Forward PS	12.69
PB Ratio	1.89
P/TBV Ratio	1.87
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	3.52
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 11.11

Current Ratio	11.11
Quick Ratio	10.61
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -69.95% and return on invested capital (ROIC) is -48.91%.

Return on Equity (ROE)	-69.95%
Return on Assets (ROA)	-42.94%
Return on Invested Capital (ROIC)	-48.91%
Return on Capital Employed (ROCE)	-46.50%
Revenue Per Employee	$649,198
Profits Per Employee	-$1.09M
Employee Count	15
Asset Turnover	0.37
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -61.57% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-61.57%
50-Day Moving Average	5.68
200-Day Moving Average	9.88
Relative Strength Index (RSI)	55.15
Average Volume (20 Days)	1,933,738

Short Selling Information

The latest short interest is 1.11 million, so 12.71% of the outstanding shares have been sold short.

Short Interest	1.11M
Short Previous Month	2.63M
Short % of Shares Out	12.71%
Short % of Float	19.09%
Short Ratio (days to cover)	0.09

Income Statement

In the last 12 months, CervoMed had revenue of $9.74 million and -$16.29 million in losses. Loss per share was -$2.02.

Revenue	9.74M
Gross Profit	-9.06M
Operating Income	-18.23M
Pretax Income	-5.04M
Net Income	-16.29M
EBITDA	n/a
EBIT	-18.23M
Loss Per Share	-$2.02

Full Income Statement

Balance Sheet

The company has $38.92 million in cash and n/a in debt, giving a net cash position of $38.92 million or $4.47 per share.

Cash & Cash Equivalents	38.92M
Total Debt	n/a
Net Cash	38.92M
Net Cash Per Share	$4.47
Equity (Book Value)	39.20M
Book Value Per Share	4.50
Working Capital	39.20M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-16.53M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is -93.04%, with operating and profit margins of -187.18% and -167.29%.

Gross Margin	-93.04%
Operating Margin	-187.18%
Pretax Margin	-167.29%
Profit Margin	-167.29%
EBITDA Margin	n/a
EBIT Margin	-187.18%
FCF Margin	n/a

Dividends & Yields

CervoMed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-203.34%
Shareholder Yield	-203.34%
Earnings Yield	-22.26%
FCF Yield	n/a

Analyst Forecast

The average price target for CervoMed is $25.43, which is 162.71% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$25.43
Price Target Difference	162.71%
Analyst Consensus	Strong Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	13.41%
EPS Growth Forecast (5Y)	-15.35%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CervoMed has an Altman Z-Score of 15.25 and a Piotroski F-Score of 1.

Altman Z-Score	15.25
Piotroski F-Score	1